As of 2024-12-13, the Relative Valuation of Terns Pharmaceuticals Inc (TERN) is (28.26) USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.59 USD, the upside of Terns Pharmaceuticals Inc based on Relative Valuation is -528.8%.
The range of the Relative Valuation is (25.82) - (30.80) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 24.0x - 30.4x | 27.2x |
| Forward P/E multiples | 24.9x - 29.7x | 27.3x |
| Fair Price | (25.82) - (30.80) | (28.26) |
| Upside | -491.8% - -567.3% | -528.8% |
| Date | P/E |
| 2024-12-10 | -6.82 |
| 2024-12-09 | -6.35 |
| 2024-12-06 | -6.32 |
| 2024-12-05 | -6.21 |
| 2024-12-04 | -6.83 |
| 2024-12-03 | -6.13 |
| 2024-12-02 | -5.93 |
| 2024-11-29 | -6.02 |
| 2024-11-27 | -6.11 |
| 2024-11-26 | -5.67 |
| 2024-11-25 | -5.58 |
| 2024-11-22 | -5.58 |
| 2024-11-21 | -5.51 |
| 2024-11-20 | -5.40 |
| 2024-11-19 | -5.70 |
| 2024-11-18 | -5.50 |
| 2024-11-15 | -5.95 |
| 2024-11-14 | -6.32 |
| 2024-11-13 | -6.54 |
| 2024-11-12 | -6.91 |
| 2024-11-11 | -7.19 |
| 2024-11-08 | -7.04 |
| 2024-11-07 | -6.81 |
| 2024-11-06 | -6.98 |
| 2024-11-05 | -6.91 |
| 2024-11-04 | -6.85 |
| 2024-11-01 | -6.69 |
| 2024-10-31 | -6.62 |
| 2024-10-30 | -6.64 |
| 2024-10-29 | -6.64 |
| 2024-10-28 | -6.28 |
| 2024-10-25 | -6.43 |
| 2024-10-24 | -6.51 |
| 2024-10-23 | -6.74 |
| 2024-10-22 | -7.23 |
| 2024-10-21 | -6.98 |
| 2024-10-18 | -7.15 |
| 2024-10-17 | -7.23 |
| 2024-10-16 | -7.38 |
| 2024-10-15 | -7.33 |
| 2024-10-14 | -7.35 |
| 2024-10-11 | -7.40 |
| 2024-10-10 | -7.14 |
| 2024-10-09 | -7.60 |
| 2024-10-08 | -7.53 |
| 2024-10-07 | -7.57 |
| 2024-10-04 | -7.98 |
| 2024-10-03 | -7.91 |
| 2024-10-02 | -7.91 |
| 2024-10-01 | -7.81 |